Source: Okayama University (JAPAN), Public Relations and Information Strategy
For immediate release: 29 Jun 2017
Okayama University research: Inorganic biomaterials for soft-tissue adhesion
(Okayama, 29 Jun) Researchers at Okayama University describe in Acta Biomaterialia a new type of biocompatible adhesive material. The adhesive, made from nanoparticles of hydroxyapatite, glues both synthetic hydrogels and mouse soft tissue, providing a promising alternative to organic materials currently in use for clinical applications.
As an alternative to surgical stitching with suture, the practice of using adhesive organic materials for joining soft tissue has been around for decades. However, the currently used clinical adhesives often suffer from limited biocompatibility and/or sub-optimal adhesive strength. A team of researchers led by Takuya Matsumoto from Okayama University and colleagues has now identified a class of biocompatible–biodegradable compounds showing promising adhesion properties when applied to mouse soft tissues.
The scientists relied on the recent discovery that certain nanostructured materials display remarkable adhesiveness. For example, introducing a dispersion of silicon oxide nanoparticles between two hydrogels results in rapid adhesion of the hydrogels — an effect now developed further for industrial, non-clinical applications. In order to achieve the level of biocompatibility required for clinical usage, Matsumoto and colleagues experimented with nanoparticles of hydroxyapatite (HAp), an inorganic material found in human hard tissues such as bones and teeth. HAp-composites are routinely used for orthopedic and dental implants, as well as in tissue engineering. The researchers reckoned that dispersions of nanoparticulate HAp should behave as biocompatible adhesives — an idea they were able to confirm experimentally.
Matsumoto and colleagues first examined the effect of HAp-nanoparticle dispersions on the adhesion of synthetic hydrogels; the presence of HAp clearly enhanced the level of adhesion. Drying the dispersions — resulting in solid HAp ‘plates’ — increased the cohesion between the HAp nanoparticles, and using the plates as the adhesive agent then led to even better inter-hydrogel adhesion. The scientists then tested the HAp plates on different mouse soft tissues: muscle, lung, kidney and other tissues could be successfully glued together. An adhesion strength at least twice as large as obtained with a commercial organic glue was observed for mouse skin tissues.
The findings of Matsumoto and colleagues are not only relevant for developing new procedures for surgical-wound healing, but also for drug-delivery technologies — the potential of hydrogels as drug containers has long been recognized. In the words of the researchers: “our results will help not only in developing an efficient approach to close incised soft tissues, but also in finding novel ways to integrate soft tissues with synthetic hydrogels (such as drug reservoirs).”
Hydroxyapatite (HAp), also known as hydroxylapatite, is a calcium-containing mineral occurring in human bones and teeth. Synthetic HAp is often used as a coating for prostethic implants, such as hip, bone or teeth replacements, as it is believed to stimulate osseointegration. The experiments of Takuya Matsumato from Okayama University and colleagues have now demonstrated the potential of dispersions of HAp nanoparticles as biocompatible, inorganic adhesive materials.
A hydrogel is a material consisting of a three-dimensional network of hydrophylic (i.e. not water-repellent) polymeric chains with water molecules in between. Hydrogels can contain up to 90% water, and are used in various biotechnological and medical applications. They are also used to test the adhesive properties of biomaterials and drug-delivery systems, as in the study of Matsumato and colleagues: tests of the adhesiveness of HAp nanoparticle dispersions led to the identification of a promising biocompatible adhesive capable of gluing mouse soft tissues together.
Masahiro Okada, Akira Nakai, Emilio Satoshi Hara, Tetsushi Taguchi, Takayoshi Nakano & Takuya Matsumoto. Biocompatible nanostructured solid adhesives for biological soft tissues. Acta Biomaterialia, 5 May , 2017.
DOI: doi: 10.1016/j.actbio.2017.05.014.
Reference (Okayama University e-Bulletin & OU-MRU) : Professor Matsumoto’s team
OU-MRU Vol.13：Peptide directs artificial tissue growth
Professor Takuya Matsumoto, D.D.S., Ph.D.
Department of Biomaterials, Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences,
Okayama University, Shikata-cho 2-5-1,
Okayama city, Okayama 700-8558, Japan
For inquiries, please contact us by replacing (a) with the @ mark.
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations and Information Strategy
E-mail: www-adm (a) adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
About Okayama University (You Tube): https://www.youtube.com/watch?v=iDL1coqPRYIOkayama University Image Movie (You Tube): https://www.youtube.com/watch?v=KU3hOIXS5kk
Okayama University Medical Research Updates （OU-MRU）
Vol.1：Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testingVol.2：Ensuring a cool recovery from cardiac arrestVol.3：Organ regeneration research leaps forwardVol.4：Cardiac mechanosensitive integratorVol.5：Cell injections get to the heart of congenital defectsVol.6：Fourth key molecule identified in bone developmentVol.7：Anticancer virus solution provides an alternative to surgeryVol.8：Light-responsive dye stimulates sight in genetically blind patientsVol.9：Diabetes drug helps towards immunity against cancerVol.10：Enzyme-inhibitors treat drug-resistant epilepsyVol.11：Compound-protein combination shows promise for arthritis treatmentVol.12：Molecular features of the circadian clock system in fruit fliesVol.13：Peptide directs artificial tissue growthVol.14：Simplified boron compound may treat brain tumoursVol.15：Metamaterial absorbers for infrared inspection technologiesVol.16：Epigenetics research traces how crickets restore lost limbsVol.17：Cell research shows pathway for suppressing hepatitis B virusVol.18：Therapeutic protein targets liver diseaseVol.19：Study links signalling protein to osteoarthritisVol.20：Lack of enzyme promotes fatty liver disease in thin patientsVol.21：Combined gene transduction and light therapy targets gastric cancerVol.22：Medical supportive device for hemodialysis catheter punctureVol.23：Development of low cost oral inactivated vaccines for dysenteryVol.24：Sticky molecules to tackle obesity and diabetesVol.25：Self-administered aroma foot massage may reduce symptoms of anxietyVol.26：Protein for preventing heart failureVol.27：Keeping cells in shape to fight sepsisVol.28：Viral-based therapy for bone cancerVol.29：Photoreactive compound allows protein synthesis control with lightVol.30：Cancer stem cells’ role in tumor growth revealedVol.31：Prevention of RNA virus replicationVol.32：Enzyme target for slowing bladder cancer invasionVol.33：Attacking tumors from the insideVol.34：Novel mouse model for studying pancreatic cancerVol.35：Potential cause of Lafora disease revealedVol.36：Overloading of protein localization triggers cellular defectsVol.37：Protein dosage compensation mechanism unravelledVol.38：Bioengineered tooth restoration in a large mammalVol.39：Successful test of retinal prosthesis implanted in ratsVol.40：Antibodies prolong seizure latency in epileptic mice